OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 70 filers reported holding OVID THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $99,840 | +17.1% | 26,000 | 0.0% | 0.00% | – |
| Q2 2023 | $85,280 | +27.1% | 26,000 | 0.0% | 0.00% | – |
| Q1 2023 | $67,080 | +38.7% | 26,000 | 0.0% | 0.00% | – |
| Q4 2022 | $48,360 | +2.9% | 26,000 | 0.0% | 0.00% | – |
| Q3 2022 | $47,000 | -14.5% | 26,000 | 0.0% | 0.00% | – |
| Q2 2022 | $55,000 | -32.1% | 26,000 | 0.0% | 0.00% | – |
| Q1 2022 | $81,000 | +224.0% | 26,000 | +225.0% | 0.00% | – |
| Q4 2021 | $25,000 | -71.3% | 8,000 | -69.2% | 0.00% | – |
| Q3 2021 | $87,000 | -13.9% | 26,000 | 0.0% | 0.00% | – |
| Q2 2021 | $101,000 | +40.3% | 26,000 | +44.4% | 0.00% | – |
| Q1 2021 | $72,000 | +75.6% | 18,000 | 0.0% | 0.00% | – |
| Q4 2020 | $41,000 | -60.2% | 18,000 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $103,000 | -22.0% | 18,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $132,000 | +149.1% | 18,000 | 0.0% | 0.00% | – |
| Q1 2020 | $53,000 | -28.4% | 18,000 | 0.0% | 0.00% | – |
| Q4 2019 | $74,000 | +27.6% | 18,000 | 0.0% | 0.00% | – |
| Q3 2019 | $58,000 | – | 18,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWH Capital, L.P. | 230,000 | $407,000 | 0.69% |
| BVF INC/IL | 3,293,000 | $5,829,000 | 0.65% |
| COWEN INC. | 1,101,414 | $1,950,000 | 0.21% |
| ARMISTICE CAPITAL, LLC | 1,780,000 | $3,151,000 | 0.17% |
| Granite Point Capital Management, L.P. | 417,857 | $740,000 | 0.07% |
| Redmile Group, LLC | 737,550 | $1,305,000 | 0.04% |
| Tekla Capital Management LLC | 496,977 | $880,000 | 0.04% |
| Fairpointe Capital LLC | 101,000 | $179,000 | 0.01% |
| Alyeska Investment Group, L.P. | 225,000 | $398,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,440 | $149,000 | 0.00% |